Brendan P. Eckelman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Inhibrx Biosciences, Inc. (INBX)
Proxy statement
Start not stated–2025-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Inhibrx Biosciences, Inc. (INBX) | Former Chief Scientific Officer | $535,600 | $2,627,592 |
| 2023 | Inhibrx Biosciences, Inc. (INBX) | Former Chief Scientific Officer | $520,000 | $1,451,958 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.